切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - Proteasome - Prk - Calcium-Activated Potassium (KCa) Channels - M5 Receptors

19件产品中的 1-10

页面
每页
清除全部
  1. VR23
    B6026 VR23
    Target: Proteasome
    Summary: 蛋白酶抑制剂
      ≥45.55 mg/mL
      insoluble in H2O
  2. Dequalinium Chloride
    B2191 Dequalinium Chloride
    中文名: 地喹氯铵
    Target: PKC|Calcium-Activated Potassium (KCa) Channels
    Summary: PKC抑制剂
      insoluble in DMSO
      insoluble in H2O
  3. PYR-41
    B1492 PYR-41
     2 Citation
    Target: Proteasome
    Summary: 泛素活化酶(E1)抑制剂
      ≥18.55 mg/mL
      insoluble in H2O
  4. Atropine sulfate monohydrate
    A8369 Atropine sulfate monohydrate
    中文名: 硫酸阿托品一水合物
    Target: M3 Receptors|M1 Receptors|M2 Receptors|M4 Receptors|M5 Receptors
    Summary: MAChRs拮抗剂
      ≥34.74 mg/mL
      ≥56.5 mg/mL
  5. Zonisamide
    A5354 Zonisamide
    中文名: 唑尼沙胺
    Target: Voltage-gated Sodium (NaV) Channels|Voltage-gated Calcium Channels (CaV)|Carbonic Anhydrases|Calcium-Activated Potassium (KCa) Channels
    Summary: 抗惊厥和机械效应的抗癫痫药
      ≥8.35 mg/mL
      insoluble in H2O
  6. GSK690693
    A5072 GSK690693
    Target: Akt|PKC|PKG|PKA|Prk
    Summary: ATP竞争性的Pan-AKT抑制剂
      ≥21.25 mg/mL
      insoluble in H2O
  7. TRAM-34
    A1888 TRAM-34
    Target: Calcium-Activated Potassium (KCa) Channels
    Summary: KCa3.1阻断剂
      ≥17.25 mg/mL
      insoluble in H2O
  8. AM 114
    A8163 AM 114
     2 Citation
    Target: Proteasome
    Summary: 20S蛋白酶体抑制剂
      ≥16.65 mg/mL
      insoluble in H2O
  9. Carfilzomib (PR-171)
    A1933 Carfilzomib (PR-171)
     10 Citation
    中文名: 卡非佐米
    Target: Proteasome
    Summary: 蛋白酶体抑制剂
      ≥35.99 mg/mL
      insoluble in H2O
  10. Bortezomib (PS-341)
    A2614 Bortezomib (PS-341)
     24 Citation
    中文名: 硼替佐米
    Target: Proteasome
    Summary: 蛋白酶体抑制剂
      ≥19.21 mg/mL
      insoluble in H2O

19件产品中的 1-10

页面
每页